Topleucon (molgramostim biosimilar)
/ Xiamen Amoytop Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 12, 2013
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
(clinicaltrials.gov)
- P2; N=40; Recruiting; Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
New P2 trial
1 to 1
Of
1
Go to page
1